Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Proponents often highlight the potential for meaningful therapeutic gains, especially in diseases where conventional therapies have proven ineffective. However, crucially important to consider the substantial financial investment associated with CPI st